[
    {
        "releaseTime": "May-15-23 01:00PM",
        "title": "Why Are CRISPR Therapeutics Charts Saying 'Buy'?",
        "publisher": "(TheStreet.com)",
        "webUrl": "https://finance.yahoo.com/m/55f43173-68bc-37f7-b499-1da9c8d3921d/why-are-crispr-therapeutics.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-13-23 08:45AM",
        "title": "Is CRISPR Therapeutics Stock a Buy Now?",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/1595e44b-099f-3d30-b303-182eae637b99/is-crispr-therapeutics-stock.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-11-23 03:13PM",
        "title": "Why These 3 Nasdaq Stocks Were Glowing Green This Week",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/9ce515c0-1ca5-3063-84ca-357d094055ba/why-these-3-nasdaq-stocks.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-10-23 10:53AM",
        "title": "CRISPR Therapeutics Stock Sees Relative Strength Rating Rise To 89",
        "publisher": "(Investor's Business Daily) +6.86%",
        "webUrl": "https://finance.yahoo.com/m/cd669314-4820-3175-aca0-7bde66348b86/crispr-therapeutics-stock.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-10-23 06:11AM",
        "title": "CRISPR Therapeutics First Quarter 2023 Earnings: Beats Expectations",
        "publisher": "(Simply Wall St.)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-first-quarter-2023-101125774.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-09-23 06:44PM",
        "title": "Analyst Report: CRISPR Therapeutics AG",
        "publisher": "(Morningstar Research) +13.33%",
        "webUrl": "https://finance.yahoo.com/m/5dc24e4c-fb3c-3449-8d53-2e6e992c28fa/analyst-report%3A-crispr.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-09-23 02:25PM",
        "title": "Why CRISPR Therapeutics Stock Is on Fire Today",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/d764dc95-e1d5-32fc-af2e-3e29bed7f34e/why-crispr-therapeutics-stock.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-09-23 08:31AM",
        "title": "CRISPR Therapeutics (CRSP) Q1 Earnings and Revenues Beat",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-crsp-q1-earnings-123112050.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-08-23 05:15PM",
        "title": "CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Tops Revenue Estimates",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-reports-211509176.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-08-23 04:01PM",
        "title": "CRISPR Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results",
        "publisher": "(GlobeNewswire)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-200100628.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-04-23 10:38AM",
        "title": "1 Incredibly Undervalued Growth Stock to Buy Hand Over Fist in May",
        "publisher": "(Motley Fool) +7.99%",
        "webUrl": "https://finance.yahoo.com/m/9a2de457-9206-33ae-a83b-f44f4e24c43c/1-incredibly-undervalued.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-04-23 05:30AM",
        "title": "3 Top Healthcare Stocks to Buy in May",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/6c9aaacb-71a5-3f65-a2d8-d28264c34775/3-top-healthcare-stocks-to.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-02-23 12:49PM",
        "title": "CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-crsp-report-q1-earnings-164904976.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-02-23 08:00AM",
        "title": "CRISPR Therapeutics to Participate Upcoming Investor Conferences",
        "publisher": "(GlobeNewswire)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-participate-upcoming-investor-120000326.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-02-23 05:53AM",
        "title": "3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/ec9d0835-587f-31f8-bb09-fe1289b7ff73/3-growth-stocks-cathie-wood.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "May-01-23 08:20PM",
        "title": "Why the human genome could be health cares holy grail",
        "publisher": "(Yahoo Finance Video)",
        "webUrl": "https://finance.yahoo.com/video/why-human-genome-could-healthcare-002054101.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-27-23 05:50PM",
        "title": "CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-gains-215009530.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-27-23 08:15AM",
        "title": "Is It Too Late to Buy CRISPR Stock?",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/c2bc845d-f191-3d6e-b2c2-21095fd948cf/is-it-too-late-to-buy-crispr.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-26-23 02:10PM",
        "title": "12 Gene Editing Stocks With the Best Long-Term Potential",
        "publisher": "(Insider Monkey)",
        "webUrl": "https://finance.yahoo.com/news/12-gene-editing-stocks-best-181003764.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-26-23 10:07AM",
        "title": "Why CRISPR Therapeutics Just Became an Even Better Buy",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/973ee0c2-f4d7-36c5-b1b4-8f7df46aefb2/why-crispr-therapeutics-just.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-25-23 06:00AM",
        "title": "3 Biotech Stocks to Watch After Johnson & Johnsons Earnings Beat",
        "publisher": "(InvestorPlace)",
        "webUrl": "https://finance.yahoo.com/news/3-biotech-stocks-watch-johnson-100039955.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-24-23 06:00PM",
        "title": "CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-stock-220010077.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-23-23 02:00PM",
        "title": "The Best Stocks to Invest $20,000 in Right Now",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/9d3ed00b-6f6c-310c-9f83-63489ccda778/the-best-stocks-to-invest.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-23-23 09:53AM",
        "title": "Buy the Dip: 2 Top Stocks to Snatch Up Now",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/be598d8c-ceb5-3113-b4ea-9876ef68094b/buy-the-dip%3A-2-top-stocks-to.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-22-23 06:18AM",
        "title": "3 Stocks With Huge Catalysts on the Way",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/cddf31df-5d7c-35b1-8f8b-0343629e1c2e/3-stocks-with-huge-catalysts.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-21-23 01:19PM",
        "title": "We're Not Very Worried About CRISPR Therapeutics' (NASDAQ:CRSP) Cash Burn Rate",
        "publisher": "(Simply Wall St.)",
        "webUrl": "https://finance.yahoo.com/news/were-not-very-worried-crispr-171913091.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-21-23 09:49AM",
        "title": "Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/vertex-vrtx-report-q1-earnings-134901141.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-21-23 07:30AM",
        "title": "2 Growth Stocks That Could Keep Growing for Decades",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/9556bc16-0ef6-389e-8a88-d7759d09c82e/2-growth-stocks-that-could.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-20-23 06:24PM",
        "title": "Top 10 CRISPR Stocks To Buy",
        "publisher": "(Insider Monkey) -6.71%",
        "webUrl": "https://finance.yahoo.com/news/top-10-crispr-stocks-buy-222413508.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-20-23 10:07AM",
        "title": "The Top 3 Biotech Stocks to Watch in 2023",
        "publisher": "(InvestorPlace)",
        "webUrl": "https://finance.yahoo.com/news/top-3-biotech-stocks-watch-140705892.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-18-23 06:40AM",
        "title": "3 High-Growth Biotech Stocks Poised for Success in 2023",
        "publisher": "(InvestorPlace)",
        "webUrl": "https://finance.yahoo.com/news/3-high-growth-biotech-stocks-104045550.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-18-23 05:30AM",
        "title": "The Top Healthcare Stocks to Buy With $100",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/82fdf7f5-8395-3b56-a6b7-5c4525b86e62/the-top-healthcare-stocks-to.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-17-23 04:05PM",
        "title": "Why CRISPR Therapeutics Stock Is Marching Higher Today",
        "publisher": "(Motley Fool) +7.91%",
        "webUrl": "https://finance.yahoo.com/m/af7ef291-f033-301d-a70d-329884a825be/why-crispr-therapeutics-stock.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-17-23 02:50PM",
        "title": "Why Shares of Editas Medicine Rose Monday",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/ab1e67ee-b350-3e1a-8d5b-d67c70060aa3/why-shares-of-editas-medicine.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-16-23 05:30AM",
        "title": "Better Growth Stock: Axsome vs. CRISPR Therapeutics",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/200e7f85-bc4d-390c-8c34-b0c36280008b/better-growth-stock%3A-axsome.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-14-23 06:00PM",
        "title": "CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-dips-220010720.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-14-23 12:49PM",
        "title": "Regulus (RGLS) Surges on Enrollment Completion for RGLS8429",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/regulus-rgls-surges-enrollment-completion-164904166.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-14-23 10:23AM",
        "title": "Is CRISPR Therapeutics Stock a Buy Now?",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/ddc0ae63-843d-37e1-b75f-269be5cfbecf/is-crispr-therapeutics-stock.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-14-23 09:40AM",
        "title": "Is BioRad Laboratories (BIO) Stock Outpacing Its Medical Peers This Year?",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/biorad-laboratories-bio-stock-outpacing-134001733.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-14-23 03:13AM",
        "title": "CRISPR Therapeutics AG (CRSP) Soars 16.3%: Is Further Upside Left in the Stock?",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-soars-071307912.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-13-23 04:01PM",
        "title": "CRISPR Therapeutics to Participate in Needhams 22nd Annual Healthcare Conference",
        "publisher": "(GlobeNewswire) +16.31%",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-participate-needham-22nd-200100190.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-13-23 03:53PM",
        "title": "Crispr Therapeutics stock jumps following analyst upgrade from Cantor Fitzgerald",
        "publisher": "(Yahoo Finance Video)",
        "webUrl": "https://finance.yahoo.com/video/crispr-therapeutics-stock-jumps-following-195353330.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-13-23 11:58AM",
        "title": "Why Shares of CRISPR Therapeutics Jumped Thursday",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/b17e4710-8d14-3557-8806-c035aa8d3348/why-shares-of-crispr.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-13-23 10:15AM",
        "title": "2 Nasdaq Growth Stocks That Are Screaming Buys in April",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/3bad3859-e3fb-3462-8aff-feb9fc168537/2-nasdaq-growth-stocks-that.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-13-23 05:30AM",
        "title": "These Up-and-Coming Stocks Are Screaming Buys Right Now",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/d4424176-cd5e-35d1-a3ba-f8fab3f3c835/these-up-and-coming-stocks.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-12-23 06:10PM",
        "title": "UPDATE 1-Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group",
        "publisher": "(Reuters)",
        "webUrl": "https://finance.yahoo.com/news/1-vertex-crisprs-gene-editing-221058308.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-12-23 05:31PM",
        "title": "Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group",
        "publisher": "(Reuters)",
        "webUrl": "https://finance.yahoo.com/news/vertex-crisprs-gene-editing-therapy-213109534.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-12-23 09:55AM",
        "title": "Wall Street Analysts Think CRISPR Therapeutics AG (CRSP) Could Surge 105.26%: Read This Before Placing a Bet",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/wall-street-analysts-think-crispr-135501194.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-12-23 05:30AM",
        "title": "Could This Move Make Vertex's Next Blockbuster Even Bigger?",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/3f4d95b3-4587-352c-9f9f-def4f72392a6/could-this-move-make-vertex%27s.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-09-23 07:45AM",
        "title": "Where Will CRISPR Therapeutics Be in 5 Years?",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/129ca92a-cc00-39f8-8fac-919e462e263f/where-will-crispr.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-08-23 05:30AM",
        "title": "CRISPR Stock: Bull vs. Bear",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/580bab95-8940-3ef6-95c0-dd74c9be09bd/crispr-stock%3A-bull-vs.-bear.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-06-23 12:19PM",
        "title": "MorphoSys Up on Finishing Early Enrolment in Myelofibrosis Study",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/morphosys-finishing-early-enrolment-myelofibrosis-161904521.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-06-23 10:23AM",
        "title": "Here's Why You Should Add Ligand (LGND) Stock to Your Portfolio",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/heres-why-add-ligand-lgnd-142302905.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-06-23 08:00AM",
        "title": "What's the Better Dip to Buy: CRISPR Therapeutics vs. Bluebird Bio",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/63ed8a28-18c6-36d4-87cf-0e555cefd738/what%27s-the-better-dip-to-buy%3A.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-05-23 12:25PM",
        "title": "AstraZeneca's (AZN) Drug Combo Meets Ovarian Cancer Study Goal",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/astrazenecas-azn-drug-combo-meets-162504788.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-05-23 11:42AM",
        "title": "VBI Vaccines (VBIV) Down 53% on Initiating Restructuring Plans",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/vbi-vaccines-vbiv-down-53-154203650.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-05-23 10:11AM",
        "title": "2 Under-the-Radar Biotech Stocks to Buy in 2023",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/0861f394-8d9c-3d30-bcc4-ba2f2adb27cb/2-under-the-radar-biotech.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-04-23 02:00PM",
        "title": "Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/cd161530-68ba-3535-a336-2aaaf5775b79/vertex-is-1-step-closer-to.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-04-23 01:32PM",
        "title": "CRISPR (CRSP) & Vertex Complete BLA Submission for Exa-Cel",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-crsp-vertex-complete-bla-173205520.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-04-23 12:43PM",
        "title": "Ascendis (ASND) Down on Hypoparathyroidism Drug NDA Deficiencies",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/ascendis-asnd-down-hypoparathyroidism-drug-164304067.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-03-23 06:15PM",
        "title": "CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-gains-221510682.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-03-23 08:57AM",
        "title": "Emergent Biosciences (EBS) Surges 28% in a Week: Here's Why",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/emergent-biosciences-ebs-surges-28-125712309.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-03-23 08:00AM",
        "title": "Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia",
        "publisher": "(Business Wire)",
        "webUrl": "https://finance.yahoo.com/news/vertex-crispr-therapeutics-complete-submission-120000960.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-01-23 05:30AM",
        "title": "Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/aa88a08e-8ec6-3811-8c3b-a5af3596a3c1/here%27s-a-new-million-dollar.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-31-23 09:00AM",
        "title": "This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market. Here's What It Means for Investors",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/9040aa6a-9bf6-3fba-bcf3-ebf27dba207c/this-top-growth-stock-is.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-31-23 05:30AM",
        "title": "5 Bargain-Basement Stocks to Buy Right Now",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/4c828b33-b502-3f2a-b788-41a08e7d2931/5-bargain-basement-stocks-to.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-30-23 08:45AM",
        "title": "2 Reasons to Sell Editas Medicine Stock and 1 Reason to Buy It",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/09493797-03b3-3950-b782-8d0457c304a2/2-reasons-to-sell-editas.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 10:23PM",
        "title": "The 3 Best Growth Stocks to Buy in the Biotech Sector",
        "publisher": "(InvestorPlace)",
        "webUrl": "https://finance.yahoo.com/news/3-best-growth-stocks-buy-022348447.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 08:54PM",
        "title": "7 Biotech Stocks to Buy for Breakthrough Treatments and Cures",
        "publisher": "(InvestorPlace)",
        "webUrl": "https://finance.yahoo.com/news/7-biotech-stocks-buy-breakthrough-005448983.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 04:40PM",
        "title": "12 Most Promising Healthcare Stocks According to Analysts",
        "publisher": "(Insider Monkey)",
        "webUrl": "https://finance.yahoo.com/news/12-most-promising-healthcare-stocks-204054903.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 04:20PM",
        "title": "11 Most Promising Gene Editing Stocks According to Analysts",
        "publisher": "(Insider Monkey)",
        "webUrl": "https://finance.yahoo.com/news/11-most-promising-gene-editing-202010308.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 12:01PM",
        "title": "Biomea (BMEA) Up 99% on Upbeat Data From Type II Diabetes Study",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/biomea-bmea-99-upbeat-data-160104500.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 09:40AM",
        "title": "Is CRISPR Therapeutics (CRSP) Stock Outpacing Its Medical Peers This Year?",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-crsp-stock-outpacing-134001363.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 08:00AM",
        "title": "CRISPR Therapeutics Announces Departure of Board Member",
        "publisher": "(GlobeNewswire)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-announces-departure-board-120000289.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-28-23 11:04AM",
        "title": "Amicus (FOLD) Gets Pompe Disease Treatment Approval in Europe",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/amicus-fold-gets-pompe-disease-150403877.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-28-23 10:41AM",
        "title": "Vertex (VRTX) Inks Licensing Deal With CRISPR for Diabetes Drug",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/vertex-vrtx-inks-licensing-deal-144102283.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-27-23 12:27PM",
        "title": "Incyte's (INCY) Pemazyre Gets Approval to Treat MLNs in Japan",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/incytes-incy-pemazyre-gets-approval-162704209.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-27-23 08:00AM",
        "title": "Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertexs Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes",
        "publisher": "(Business Wire)",
        "webUrl": "https://finance.yahoo.com/news/vertex-crispr-therapeutics-announce-licensing-120000512.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-27-23 06:00AM",
        "title": "Could CRISPR Therapeutics Become the Next Moderna?",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/55dc9f77-eb15-3922-8063-c28cd57b20d9/could-crispr-therapeutics.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-25-23 09:53AM",
        "title": "CRISPR Therapeutics AG's (NASDAQ:CRSP) latest 5.1% decline adds to one-year losses, institutional investors may consider drastic measures",
        "publisher": "(Simply Wall St.)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ags-nasdaq-crsp-135329909.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-25-23 09:30AM",
        "title": "Could This Stock Become the Tesla of Its Industry?",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/8fe86b45-f8d6-3ee5-a9bc-555ee418ac25/could-this-stock-become-the.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-25-23 09:17AM",
        "title": "The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket",
        "publisher": "(InvestorPlace)",
        "webUrl": "https://finance.yahoo.com/news/3-best-crispr-stocks-buy-131725442.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-24-23 03:02PM",
        "title": "Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/moderna-mrna-inks-genetic-medicines-190207047.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-23-23 11:30AM",
        "title": "CRISPR Therapeutics AG (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-down-153003144.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-23-23 11:09AM",
        "title": "Biohaven (BHVN) Acquires Dual Inhibitor for Brain Disorders",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/biohaven-bhvn-acquires-dual-inhibitor-150903276.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-23-23 10:07AM",
        "title": "This Cathie Wood Stock Could Nearly Double, According to Wall Street",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/9497dfa1-eccb-3f19-b7ac-ddf151b06b68/this-cathie-wood-stock-could.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-22-23 08:34AM",
        "title": "Intellia's (NTLA) HAE Therapy Granted RMAT by the FDA",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/intellias-ntla-hae-therapy-granted-123412208.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-22-23 07:37AM",
        "title": "Zacks Industry Outlook Highlights CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus Pharmaceuticals and Kala Pharmaceuticals",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/zacks-industry-outlook-highlights-crispr-113711703.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-21-23 06:00PM",
        "title": "CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-outpaces-220010490.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-21-23 11:59AM",
        "title": "Here's Why You Should Add CRISPR Stock to Your Portfolio",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/heres-why-add-crispr-stock-155903408.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-18-23 07:18PM",
        "title": "3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time",
        "publisher": "(InvestorPlace)",
        "webUrl": "https://finance.yahoo.com/news/3-cutting-edge-healthcare-stocks-231856148.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-18-23 06:14AM",
        "title": "3 Beaten-Down Stocks That Could Soar This Year",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/17e240c9-9a37-332e-965b-f26c9a302cfd/3-beaten-down-stocks-that.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-16-23 11:41AM",
        "title": "Bellicum (BLCM) Down on Ending Development of CAR-T Candidates",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/bellicum-blcm-down-ending-development-154103532.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-15-23 06:00PM",
        "title": "CRISPR Therapeutics AG (CRSP) Stock Moves -0.51%: What You Should Know",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-stock-220010719.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-15-23 10:39AM",
        "title": "Novo Nordisk (NVO) Follows Lilly, to Cut Insulin Prices by 75%",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/novo-nordisk-nvo-follows-lilly-143902101.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-15-23 10:22AM",
        "title": "AstraZeneca (AZN) Stock Up 5% in a Year: What Awaits in 2023?",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/astrazeneca-azn-stock-5-awaits-142202585.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-15-23 05:30AM",
        "title": "2 Top Biotech Stocks to Buy for the Long Haul",
        "publisher": "(Motley Fool)",
        "webUrl": "https://finance.yahoo.com/m/38b267a2-4bdc-3476-9cce-52ec19e0e9d6/2-top-biotech-stocks-to-buy.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-14-23 06:15PM",
        "title": "CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know",
        "publisher": "(Zacks)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-stock-221510225.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-14-23 06:02PM",
        "title": "CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting",
        "publisher": "(GlobeNewswire)",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-present-american-association-220200160.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-13-23 04:15PM",
        "title": "CRISPR Therapeutics Announces Transition of Chief Financial Officer",
        "publisher": "(GlobeNewswire) +5.78%",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-announces-transition-chief-201500002.html",
        "company": "CRSP"
    }
]